Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Knight

Showing results (571-580 of 614) with videos related to

Pageof 62
Sort By:
Prosthetics and Orthotics International|December 21, 2021
Toward improving residual limb climate within prostheses for persons with lower limb loss: a technical noteAshley D Knight, Brad D Hendershot, Todd J Sleeman, et al.
The Journal of Biological Chemistry|December 5, 2020
Multivalent lipid targeting by the calcium-independent C2A domain of synaptotagmin-like protein 4/granuphilinAml A Alnaas, Abena Watson-Siriboe, Sherleen Tran, et al.
The New England Journal of Medicine|February 22, 1996
Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study GroupJ R Berenson, A Lichtenstein, L Porter, et al.
Molecular Microbiology|January 22, 2005
Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesinJulie Bouckaert, Jenny Berglund, Mark Schembri, et al.
Science Advances|June 11, 2025
<i>Helicobacter pylori</i> CagA protein is a potent and broad-spectrum amyloid inhibitorZhen Jin, William Pallisgaard Olsen, Cecilia Mörman, et al.
British Journal of Haematology|June 24, 2009
Expanded safety experience with lenalidomide plus dexamethasone in relapsed or refractory multiple myelomaChristine Chen, Donna E Reece, David Siegel, et al.
Bioorganic & Medicinal Chemistry Letters|June 7, 2005
Aminoalkoxybenzyl pyrrolidines as novel human urotensin-II receptor antagonistsJian Jin, Dashyant Dhanak, Steven D Knight, et al.
One Health (Amsterdam, Netherlands)|September 16, 2025
Biodiversity threats and socio-ecological dynamics in Chebera Churchura National Park: A One Health approachTadesse Guadu, Berhanu Abera, Kissanet Tesfay, et al.
Prevention Science : the Official Journal of the Society for Prevention Research|June 1, 2023
Leveraging the Full Continuum of Care to Prevent Opioid Use DisorderJ D Cance, E T Adams, E J D'Amico, et al.
Nature Communications|April 14, 2026
Restorative macrophage-derived RNAseT2 stimulates muscle stem cell fusion via an SLK/N-WASP/actin bundling dependent axisMichéle Weiss-Gayet, Gaëtan Juban, Emmeran Le Moal, et al.
Pageof 62

Showing results (571-580 of 614) with videos related to

Sort By:
Pageof 62
Prosthetics and Orthotics International|December 21, 2021
Toward improving residual limb climate within prostheses for persons with lower limb loss: a technical noteAshley D Knight, Brad D Hendershot, Todd J Sleeman, et al.
The Journal of Biological Chemistry|December 5, 2020
Multivalent lipid targeting by the calcium-independent C2A domain of synaptotagmin-like protein 4/granuphilinAml A Alnaas, Abena Watson-Siriboe, Sherleen Tran, et al.
The New England Journal of Medicine|February 22, 1996
Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study GroupJ R Berenson, A Lichtenstein, L Porter, et al.
Molecular Microbiology|January 22, 2005
Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesinJulie Bouckaert, Jenny Berglund, Mark Schembri, et al.
Science Advances|June 11, 2025
<i>Helicobacter pylori</i> CagA protein is a potent and broad-spectrum amyloid inhibitorZhen Jin, William Pallisgaard Olsen, Cecilia Mörman, et al.
British Journal of Haematology|June 24, 2009
Expanded safety experience with lenalidomide plus dexamethasone in relapsed or refractory multiple myelomaChristine Chen, Donna E Reece, David Siegel, et al.
Bioorganic & Medicinal Chemistry Letters|June 7, 2005
Aminoalkoxybenzyl pyrrolidines as novel human urotensin-II receptor antagonistsJian Jin, Dashyant Dhanak, Steven D Knight, et al.
One Health (Amsterdam, Netherlands)|September 16, 2025
Biodiversity threats and socio-ecological dynamics in Chebera Churchura National Park: A One Health approachTadesse Guadu, Berhanu Abera, Kissanet Tesfay, et al.
Prevention Science : the Official Journal of the Society for Prevention Research|June 1, 2023
Leveraging the Full Continuum of Care to Prevent Opioid Use DisorderJ D Cance, E T Adams, E J D'Amico, et al.
Nature Communications|April 14, 2026
Restorative macrophage-derived RNAseT2 stimulates muscle stem cell fusion via an SLK/N-WASP/actin bundling dependent axisMichéle Weiss-Gayet, Gaëtan Juban, Emmeran Le Moal, et al.
Pageof 62